Related Experiment Videos

Gabapentin treatment in a child with delayed-onset hemichorea/hemiballismus

S V Kothare1, P Pollack, A G Kulberg

  • 1Division of Pediatric Neurology, University of Massachusetts Memorial Health Care, Worcester 01655-0318, USA.

Pediatric Neurology
|February 11, 2000
PubMed

Insights

A child experienced involuntary movements like hemichorea and hemiballismus. Gabapentin treatment showed positive results, offering a potential solution for this movement disorder.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Movement Disorders

Background:

  • Subacute onset of involuntary movements in a pediatric patient.
  • Previous right parietal cortical and subcortical stroke identified as the presumed etiology.
  • Evaluation for delayed-onset movement disorders in children.

Observation:

  • A 13-year-old female presented with left-sided hemichorea/hemiballismus.
  • Symptoms suggested a link to a prior stroke.
  • Gabapentin was administered as a therapeutic intervention.

Findings:

  • Gabapentin treatment demonstrated positive outcomes at the 6-month follow-up.
  • The medication effectively managed the hemichorea/hemiballismus symptoms.
  • Differential diagnosis for pediatric movement disorders was considered.

Implications:

  • Gabapentin is a viable treatment option for pediatric hemichorea/hemiballismus secondary to stroke.
  • This case highlights the importance of considering stroke as a cause of delayed-onset movement disorders in children.
  • Further research into gabapentin's efficacy in similar pediatric cases is warranted.

Related Concept Videos